Shares of Rivian Automotive (NASDAQ:RIVN) gained 4.11% through a.m. trading on Tuesday, bucking the downward trend in the ...

Samsara Inc. ("Samsara") (NYSE: IOT), the pioneer of the Connected Operations® Platform, and Rivian (NASDAQ: RIVN), American ...

Rivian Automotive (NasdaqGS:RIVN) recently announced a collaboration with Samsara Inc. to enhance electric fleet management, fueling investor optimism about the company's future prospects. This ...

BNP Paribas Exane analyst James Picariello raised the price target on Rivian Automotive, Inc. (NASDAQ:RIVN) from $18 to $20 and kept an “Outperform” rating. The analyst highlighted the company’s gross ...

Rivian Automotive, Inc. (NASDAQ: RIVN) today announced that on Tuesday, June 3, 2025, at 3:30PM ET, Rivian Founder and CEO RJ Scaringe will participate in a fireside chat at the TD Cowen 9th Annual ...

Rivian Automotive, Inc. today announced that on Wednesday, June 4, 2025 at 8:50 AM ET, Rivian Founder and CEO RJ Scaringe will participate in a fireside chat at the UBS Auto & Auto Tech Conference. A ...

Yahoo Finance host Allie Canal tracks today's top moving stocks and biggest market stories in this Market Minute, including Rivian's (RIVN) partnership with fleet manager Samsara (IOT), Viking (VIK) ...

Initial public offerings, or IPOs, are when a company offers its stock shares to the general public for the first time. The ...

All Remote - GitLab Inc., , the most comprehensive, intelligent DevSecOps platform, today announced that it will report its financial results for the first quarter of fiscal year 2026, which ended ...

Integral Ad Science , a leading global media measurement and optimization platform, today announced that Lisa Utzschneider, CEO, will participate in a fireside chat at the following investor ...

SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR ? Logitech International (SIX: LOGN) today announced that the Company's board of directors has approved a proposal for a Fiscal Year 2025 ...

Vir Biotechnology, Inc. , today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, and Mika Kakefuda Derynck, M.D., Executive Vice President, Therapeutic Area Head, ...